| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/26/2000 | CN1054761C Medicine for abstaining from drugs and its preparation |
| 07/26/2000 | CN1054759C Spraying agent for stopping pains |
| 07/26/2000 | CN1054758C Medicine bar for fumigation |
| 07/26/2000 | CN1054755C Stomachic tablet and its production method |
| 07/26/2000 | CN1054754C Medicinal composite for rheumatism |
| 07/26/2000 | CN1054751C Oral medicine for curing vision |
| 07/26/2000 | CN1054749C Antin sthmatic paper stuck on acupoint |
| 07/26/2000 | CN1054746C Method for application of copper slicylacetate |
| 07/26/2000 | CN1054744C Aqueous agent |
| 07/26/2000 | CN1054743C Argatroban consentrated aqueous solution |
| 07/26/2000 | CN1054742C Improvements in or relating to benzothiophenes |
| 07/26/2000 | CN1054741C Medicinal composite for eyes |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093792 Comprising first comonomer units derived from lactones, lactams, thiolactones, or nonfunctionalized cyclic carbonates, and second comonomer units derived from functionalized cyclic carbonates; medical use |
| 07/25/2000 | US6093715 Process for producing riboflavin-containing granules |
| 07/25/2000 | US6093706 Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders |
| 07/25/2000 | US6093421 Maca and antler for augmenting testosterone levels |
| 07/25/2000 | US6093420 Sustained release matrix for high-dose insoluble drugs |
| 07/25/2000 | US6093419 A transdermal patch; non-self-supporting, limp and fragile; cannot be removed from the skin and later reapplied to the skin |
| 07/25/2000 | US6093417 Comprising a penetration enhancers to diffuse the therapeutic agents through the tympanic membrane into the middle and inner ear; drug delivery |
| 07/25/2000 | US6093412 Cosmetic and dermatological compositions containing aminoalcohol derivatives containing a urea functional group and uses thereof |
| 07/25/2000 | US6093394 Vaginal lactobacillus medicant |
| 07/25/2000 | US6093393 Methods for preparing and using clonogenic fibroblasts and transfected clonogenic fibroblasts |
| 07/25/2000 | US6093391 Peptide compositions containing polyoxyethylene-polyoxypropylene block copolymers that are useful in treatment of diseases and disorders with reduced side effects, ease in administering to desired target site, |
| 07/25/2000 | US6093384 Aqueous polymer dispersions as film-forming agent comprising hybrid polymers of vinyl compounds or acrylic compounds with particles of polyesters, polyesteramides, or alkyds |
| 07/25/2000 | US6093348 Aqueous suspension of carotenoid is heated to melt the carotenoid, the suspension is then homogenized under pressure to form an emulsion, and the resulting emulsion is dried to obtain the carotenoid powder |
| 07/25/2000 | US6093181 Treatment of erectile dysfunction |
| 07/25/2000 | US6092567 Apparatus for producing a pharmaceutical product |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/20/2000 | WO2000042429A2 In vitro model for gastrointestinal inflammation |
| 07/20/2000 | WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | WO2000042050A1 Sulfated phosphatidylinositols, their preparation and use |
| 07/20/2000 | WO2000041984A1 Method and apparatus for shaping particles by ultrasonic cavitation |
| 07/20/2000 | WO2000041740A2 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | WO2000041731A1 Reverse gene therapy |
| 07/20/2000 | WO2000041730A1 A composition and method for the enhancement of the efficacy of drugs |
| 07/20/2000 | WO2000041709A1 Nasal spray based on xylometazoline and camomile extract |
| 07/20/2000 | WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 07/20/2000 | WO2000041704A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 07/20/2000 | WO2000041699A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| 07/20/2000 | WO2000041694A2 Compositions having improved stability |
| 07/20/2000 | WO2000041693A2 Compositions having improved delivery of actives |
| 07/20/2000 | WO2000041692A2 Compositions having improved stability |
| 07/20/2000 | WO2000041683A2 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids |
| 07/20/2000 | WO2000041682A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 07/20/2000 | WO2000041681A2 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST |
| 07/20/2000 | WO2000041680A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | WO2000041679A1 Genetic immunization with co-delivery of nucleic acid and cytokines |
| 07/20/2000 | WO2000041678A1 Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 07/20/2000 | WO2000041677A1 Granules for oral administration, process for producing the same, and tablets produced from the granules |
| 07/20/2000 | WO2000041676A1 Spheronised self-emulsifying system for hydrophobic and water-sensitive agents |
| 07/20/2000 | WO2000041671A2 Composition, device, and method for subcutaneous fat removal |
| 07/20/2000 | WO2000041670A2 Pharmaceutical forms and methods for penetration continuity |
| 07/20/2000 | WO2000041668A1 Method and device for producing different solid dosage forms |
| 07/20/2000 | WO2000041662A1 Face mask or bandage |
| 07/20/2000 | WO2000041659A1 Contraceptive and anti-infective barrier device |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | WO2000041538A2 Dermal compositions |
| 07/20/2000 | WO2000041528A2 Improved controlled release compositions and method |
| 07/20/2000 | WO2000041504A2 Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides |
| 07/20/2000 | WO2000041482A2 Oral administration of taxoid derivatives |
| 07/20/2000 | WO2000041481A2 Medicament forms having controlled release and containing active substances which easily dissolve in water |
| 07/20/2000 | WO2000041478A2 Agglomerates by crystallisation |
| 07/20/2000 | WO2000027437A3 Polymer grafting by polysaccharide synthases |
| 07/20/2000 | WO2000027358A8 Aqueous composition containing two acid-functional vinyl polymers |
| 07/20/2000 | WO2000021521A3 Sertraline oral concentrate |
| 07/20/2000 | WO2000021510A3 Formulations of fexofenadine |
| 07/20/2000 | WO2000019985A3 New sustained release oral formulations |
| 07/20/2000 | WO2000019984A3 Coated medicament forms with controlled active substance release |
| 07/20/2000 | WO2000018370A3 Liquid pharmaceutical for oral delivery |
| 07/20/2000 | WO2000015203A3 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/20/2000 | WO2000010598B1 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 07/20/2000 | WO2000002950A9 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | WO2000000222A9 Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 07/20/2000 | DE19901692A1 Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes A process for the production of pellets with a content of up to 90% of a pharmaceutical active ingredient by weight. |
| 07/20/2000 | DE19901687A1 Opioide Analgetika mit kontrollierter Wirkstofffreisetzung Opioid analgesics controlled release |
| 07/20/2000 | DE19901686A1 Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung Retarded tramadol with a storage-stable release profile and methods for their preparation |
| 07/20/2000 | DE19901683A1 Analgetikum mit kontrollierter Wirkstofffreisetzung Analgesic with controlled release of active ingredient |
| 07/20/2000 | DE19901383A1 Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen A process for the production of different solid dosage forms |
| 07/20/2000 | DE19901040A1 Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe Controlled release dosage forms containing highly water-soluble drugs |
| 07/20/2000 | CA2724287A1 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | CA2360370A1 Method and device for producing different solid dosage forms |
| 07/20/2000 | CA2360358A1 Compositions having improved stability |
| 07/20/2000 | CA2360243A1 Use of lactobacillus salivarius |
| 07/20/2000 | CA2360227A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | CA2359474A1 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | CA2359381A1 Medicament forms having controlled release and containing active substances which easily dissolve in water |
| 07/20/2000 | CA2359273A1 Pharmaceutical formulations containing an opioid and an .alpha.-agonist |
| 07/20/2000 | CA2356944A1 Compositions having improved stability |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/19/2000 | EP1020494A1 Entrapment of vitamines with an elastomeric silicone polyether |
| 07/19/2000 | EP1020464A1 Paroxetine methansulfonate |
| 07/19/2000 | EP1020463A1 Paroxetine methanesulfonate |
| 07/19/2000 | EP1020219A1 Nanoemulsion based on alkylether citrates and uses thereof in the fields of cosmetics, dermatology, pharmaceuticals and/or ophthalmology |
| 07/19/2000 | EP1020194A1 O/w emulsion compositions |
| 07/19/2000 | EP1020193A1 Oral preparation |
| 07/19/2000 | EP1020188A1 New use of taxoid derivatives |
| 07/19/2000 | EP1020186A2 Sustained release tramadol preparations with a storage stable release profile and process for their manufacture |
| 07/19/2000 | EP1020185A2 Opioid analgesics with controlled release |